APO-010

N/A

Report date: 2022/11/25 18:08:35

Base Information

Drug NameAPO-010
Drug Alias NameSoluble FasL (Mega-Ligand)MegaFasLAPO-010 DRPAPO-010
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionApoptosis-mediating surface antigen FAS stimulantsApoptosis stimulants
TargetsApoptosis-mediating surface antigen FAS
Therapy Area/IndicationsMultiple MyelomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesValerio Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A